Nutritional Outlook magazine just published an article entitled “Preclinical research shows that COVID-19 infection may dysregulate NAD+ synthesis”. Key excerpt:

“The study provides important evidence about the nature of immune defense to the virus, but further research is necessary to determine potential treatments.”

“Our data says that the innate immune defense against viral infection depends on NAD and that it may be more effective at higher NAD,” says Brenner.” (NOTE: Dr Brenner is Chief Scientific Advisor to Chromadex who sell NR (TRU Niagen))

“We’re looking at whether nicotinamide riboside (NR), a vitamin that is available as Niagen (TRU Niagen), will protect against viral infection in cells and animals. We need a bit more proof of concept, and then we’ll be able to do human clinical studies.”

“While the preclinical research described here is promising, it was published as a preprint and has yet to be peer reviewed.”

Full article HERE.

Pre-Clinical abstract HERE.

RELATED:

  • FAQs on taking NAD boosting vitamin supplement Nicotinamide Riboside (NR) can be found HERE.
  • NR supplementation may have helped sufferers of these diseases & conditions (Consumer Reviews)

FOLLOW us on Twitter @RaisingNAD